References and Recommended Reading
Rodriguez A, Bernardi V, Navia J, et al.: Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II). 30 day and one-year follow-up results. J Am Coll Cardiol 2001, 37:51–58.
Puel J, Karouny E, Marco F, et al.: Angioplasty versus surgery in multi-vessel disease: immediate results and in-hospital outcome in a randomized prospective study [abstract]. Circulation 1992, 86(Suppl I):372.
Rodriguez A, Boullon F, Perez-Balino, et al.: Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in hospital results and 1 year follow-up. J Am Coll Cardiol 1993, 22:1060–1067.
RITA Trial Participants: Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993, 341:573–580.
Hamm CW, Reimers J, Ischinger T, et al.: A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary artery disease. N Engl J Med 1994, 331:1037–1043.
King SB III, Lembo NJ, Weintraub WS, et al.: A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994, 331:1044–1050.
CABRI Trial Participants: Coronary Angioplasty vs. Bypass Revascularization Investigation (CABRI) results during the first year. Lancet 1995, 346:1179–1183.
The Bypass Angioplasty Revascularization Investigation (BARI) Investigators: Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996, 335:217–225.
Ryan TJ: Present-day PTCR versus CABG: a randomized comparison with a different focus and a new result. J Am Coll Cardiol 2001, 37:59–62.
Boden W, O’Rourke R, Crawford M, et al.: Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an "invasive" as compared with a conservative management strategy. N Engl J Med 1998, 338:1785–1792.
The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators: Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000, 342:821–828.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alpert, J.S. Differences in outcome between percutaneous coronary intervention and coronary bypass grafting. Curr Cardiol Rep 3, 173–174 (2001). https://doi.org/10.1007/s11886-001-0017-x
Issue Date:
DOI: https://doi.org/10.1007/s11886-001-0017-x